The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liposomal vs conventional doxorubicin as first-line therapy in advanced soft tissue sarcomas: A tertiary US center’s 8.5-year experience.
 
Gabriel Aleixo
No Relationships to Disclose
 
Lee Hartner
Research Funding - Astex Pharmaceuticals (Inst); Linnaeus Therapeutics (Inst); PTC Therapeutics (Inst); SpringWorks Therapeutics (Inst); TRACON Pharma (Inst)
 
Mark Diamond
No Relationships to Disclose
 
Lazlo Nziga
No Relationships to Disclose
 
Daniel Lefler
No Relationships to Disclose